Monoclonal Antibody Infusions

Angie SzumlinskiAnnouncements, News

The Centers for Medicare & Medicaid Services (CMS) announced that as of November 10, 2020, Medicare beneficiaries are receiving coverage of monoclonal antibodies to treat COVID-19 with no cost-sharing during the Public Health Emergency (PHE). CMS’ coverage of monoclonal antibody infusions applies to bamianivimab, which received an Emergency Use Authorization (EUA) from the FDA on November 9. CMS anticipates that …